Home/Publication/Blume & Owl Ventures Back Personalised Cancer Care
Blume & Owl Ventures Back Personalised Cancer Care 

15 May 2025

US$ 20.00

Blume Ventures and Owl Ventures have co-led the US$16 m seed funding round of Complement 1, a health tech startup...

Price / article: US$20.00
OR existing subscriber
Related Publications

Trident Growth Partners (TGP) and Amicus Capital Partners have co-led the 7.5 bn rupees (US$82 m) funding round of SFO...

Macquarie Asset Management (MAM) is to invest jointly with South Korea’s Gabia Inc 600 bn won (US$420 m) over the ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.